Article
Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF.
Journal of translational medicine - 1 Dec 2008
Brem Harold, Golinko Michael S, Stojadinovic Olivera, Kodra Arber, Diegelmann Robert F, Vukelic Sasa, Entero Hyacinth, Coppock Donald L, Tomic-Canic Marjana
Abstract excerpt
BACKGROUND: Multiple physiologic impairments are responsible for chronic wounds. A cell line grown which retains its phenotype from patient wounds would provide means of testing new therapies. Clinical information on patients from whom cells were grown can provide insights into mechanisms of specific disease such as diabetes or biological processes such as aging. The objective of this study was 1) To culture...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
